Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Bavarian Nordic Logo
Bavarian Nordic Growth Score
60
CB Rank
32781
Heat Score
61
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention.
Founded
obfuscation
PublicPost-IPO Equity Kvistgaard, Hovedstaden, Denmark1001-5000 www.bavarian-nordic.com
Biotechnology
Health Care
Medical
Overview

Bavarian Nordic
Total Funding
obfuscation
Growth Score
60
Heat Score
61

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score60
-21 pts
in past quarter
Heat Score 61
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Bavarian Nordic

CB Rank
32781
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention.
Founded
obfuscation
PublicPost-IPO Equity Kvistgaard, Hovedstaden, Denmark1001-5000 www.bavarian-nordic.com
Biotechnology
Health Care
Medical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name Bavarian Nordic A/S
Operating Status Active
Number of Exits 
obfuscation
Stock Symbol  CPH:BAVA
Company Type For Profit
About the Company
Bavarian Nordic is a industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases.
Phone Number (453) 326-8383
Contact Email info@bavarian-nordic.com
Predictions & Insights

Growth Insight

See this Growth Insight
Bavarian Nordic is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Imvamune®/Imvanex®
A non-replicating smallpox and monkeypox vaccine designed to prevent infection in at-risk populations.
Rabipur®/RabAvert®
A vaccine for the prevention of rabies infection in humans.

Research & Development

Bavarian Nordic is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Bavarian Nordic Logo
Post-IPO Equity - Bavarian Nordic
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
European Investment Bank Logo
European Investment Bank
—
Post-IPO Debt - Bavarian Nordic Logo
Post-IPO Debt - Bavarian Nordic
—
European Investment Bank Logo
European Investment Bank
—
Post-IPO Debt - Bavarian Nordic Logo
Post-IPO Debt - Bavarian Nordic
—
European Investment Bank Logo
European Investment Bank
—
Post-IPO Debt - Bavarian Nordic Logo
Post-IPO Debt - Bavarian Nordic
—
European Investment Bank Logo
European Investment Bank
—
Post-IPO Debt - Bavarian Nordic Logo
Post-IPO Debt - Bavarian Nordic
—
European Investment Bank Logo
European Investment Bank
—
Post-IPO Debt - Bavarian Nordic Logo
Post-IPO Debt - Bavarian Nordic
—

Investments

Number of Investments 1
Number of Exits 
obfuscation
Number of Acquisitions 2
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation

Investment Breakdown

Number of Investments 1
Number of Exits 
obfuscation
Number of Acquisitions 2
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
obfuscation
Nabobil.no Logo
Nabobil.no
Yes
Corporate Round - Nabobil.no Logo
Corporate Round - Nabobil.no
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 4 Board Members and Advisors 4 Contacts 306

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

15,468
-0.83%
 in past month

IT Spend

$37.9MThis year, Bavarian Nordic is projected to spend $37.9M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Thunderbolt Logo
Thunderbolt
100
Feature Flags Logo
Feature Flags
100
Discipline Logo
Discipline
100

Actively Used Products

18Bavarian Nordic uses 18 technology products and services including HTML5, jQuery, and  Valimail, according to G2 Stack.

Active Website Tech Count

64Bavarian Nordic is actively using 64 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

236The intellectual property of Bavarian Nordic includes 155 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Bavarian Nordic has registered 81 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Bavarian Nordic's headquarters? Bavarian Nordic is located in Kvistgaard, Hovedstaden, Denmark.Who invested in Bavarian Nordic? Bavarian Nordic has 2 investors including European Investment Bank and  National Institutes of Health.When was the last funding round for Bavarian Nordic? Bavarian Nordic closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Bavarian Nordic's competitors? Alternatives and possible competitors to Bavarian Nordic may include LimmaTech Biologics, Fab'entech, and  Osivax.How much funding has Bavarian Nordic raised to date? Bavarian Nordic has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(53d292a 1)
|